Lantern Pharma Inc.
LTRN
$1.77
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.07M | -3.33M | -4.07M | -4.18M | -4.33M |
| Total Depreciation and Amortization | 22.40K | 22.60K | 47.10K | 54.30K | 4.50K |
| Total Amortization of Deferred Charges | 0.00 | 33.60K | -- | -- | -- |
| Total Other Non-Cash Items | 4.03M | 263.70K | 393.90K | 208.00K | 7.40K |
| Change in Net Operating Assets | 79.40K | -763.30K | 841.10K | -656.80K | 381.90K |
| Cash from Operations | -2.94M | -3.77M | -2.79M | -4.57M | -3.94M |
| Capital Expenditure | -- | -- | 0.00 | -600.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 692.30K | 4.25M | -1.70M | 5.93M | 3.59M |
| Cash from Investing | 692.30K | 4.25M | -1.70M | 5.93M | 3.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.99M | -- | 666.20K | 971.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -139.70K | -- | -- |
| Cash from Financing | 3.99M | -- | 526.50K | 971.80K | -- |
| Foreign Exchange rate Adjustments | -700.00 | 17.60K | 3.00K | -300.00 | 27.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74M | 495.00K | -3.97M | 2.33M | -316.20K |